Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2021

Open Access 01-12-2021 | Ventricular Tachycardia | Research

Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies

Authors: Javier Jiménez-Candil, Olga Duran, Armando Oterino, Jendri Pérez, Juan Carlos Castro, Jesús Hernández, José Moríñigo, Manuel Sánchez García, Pedro L. Sánchez

Published in: BMC Cardiovascular Disorders | Issue 1/2021

Login to get access

Abstract

Background

ICD patients with episodes of nonsustained ventricular tachycardias (NSVT) are at risk of appropriate therapies. However, the relationship between the cycle length (CL) of such NSVTs and the subsequent incidence of appropriate interventions is unknown.

Methods

416 ICD patients with LVEF < 45% were studied. ICD programming was standardized. NSVT was defined as any VT of 5 or more beats at ≥ 150 bpm occurred in the first 6 months after implantation that terminated spontaneously and was not preceded by any appropriate therapy. The mean follow-up was 41 ± 27 months.

Results

We analyzed 2201 NSVTs (mean CL = 323 ms) that occurred in 250 patients; 111 of such episodes were fast (CL ≤ 300 ms). Secondary prevention (HR = 1.7; p < 0.001), number of NSVT episodes (HR = 1.05; 95% CI 1.04–1.07; p < 0.001) and beta-blocker treatment (HR = 0.7; p = 0.04) were independent predictors of appropriate interventions; however, the mean CL of NSVTs was not (p = 0.6). There was a correlation between the mean CL of NSVTs and the CL of the first monomorphic VT: r = 0.88; p < 0.001. This correlation was especially robust in individuals with > 5 NSVTs (r = 0.97; p < 0.001), with an agreement between both values greater than 95%. Patients with any fast NSVT experienced a higher incidence of VF episodes (26%) compared to those without NVSTs (3%) or with only slow NSVTs (7%); p < 0.001.

Conclusions

Unlike the burden, the CL of NSVTs is not a predictor of subsequent appropriate interventions. However, there is a close relationship between the CL of NSVTs and that of arrhythmias that will later lead to appropriate therapies.
Literature
1.
go back to reference Doval HC, Nul DR, Grancelli HO, et al. Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators. Circulation. 1996;94(12):3198–203.CrossRef Doval HC, Nul DR, Grancelli HO, et al. Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators. Circulation. 1996;94(12):3198–203.CrossRef
2.
go back to reference Verma A, Sarak B, Kaplan AJ, et al. Predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathy. Pacing Clin Electrophysiol. 2010;33(3):320–9.CrossRef Verma A, Sarak B, Kaplan AJ, et al. Predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathy. Pacing Clin Electrophysiol. 2010;33(3):320–9.CrossRef
3.
go back to reference Chen J, Johnson G, Hellkamp AS, et al. Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol. 2013;61(21):2161–8.CrossRef Chen J, Johnson G, Hellkamp AS, et al. Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol. 2013;61(21):2161–8.CrossRef
4.
go back to reference Jimenez-Candil J, Hernandez J, Perdiguero P, et al. Prognostic significance of nonsustained ventricular tachycardia episodes occurring early after implantable cardioverter-defibrillator implantation among patients with left ventricular dysfunction. Am J Cardiol. 2016;118(10):1503–10.CrossRef Jimenez-Candil J, Hernandez J, Perdiguero P, et al. Prognostic significance of nonsustained ventricular tachycardia episodes occurring early after implantable cardioverter-defibrillator implantation among patients with left ventricular dysfunction. Am J Cardiol. 2016;118(10):1503–10.CrossRef
5.
go back to reference Zhou X, Gunderson BD, Olson WH. Incidence of nonsustained and sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol. 2004;15(1):14–20.CrossRef Zhou X, Gunderson BD, Olson WH. Incidence of nonsustained and sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol. 2004;15(1):14–20.CrossRef
6.
go back to reference Makimoto H, Zielke S, Clasen L, et al. Clinical significance of precedent asymptomatic non-sustained ventricular tachycardias on subsequent ICD interventions and heart failure hospitalization in primary prevention ICD patients. Eur J Med Res. 2020;25(1):5.CrossRef Makimoto H, Zielke S, Clasen L, et al. Clinical significance of precedent asymptomatic non-sustained ventricular tachycardias on subsequent ICD interventions and heart failure hospitalization in primary prevention ICD patients. Eur J Med Res. 2020;25(1):5.CrossRef
7.
go back to reference Garcia-Alberola A, Yli-Mayry S, Block M, et al. RR interval variability in irregular monomorphic ventricular tachycardia and atrial fibrillation. Circulation. 1996;93(2):295–300.CrossRef Garcia-Alberola A, Yli-Mayry S, Block M, et al. RR interval variability in irregular monomorphic ventricular tachycardia and atrial fibrillation. Circulation. 1996;93(2):295–300.CrossRef
8.
go back to reference Swerdlow CD, Chen PS, Kass RM, Allard JR, Peter CT. Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol. 1994;23(6):1342–55.CrossRef Swerdlow CD, Chen PS, Kass RM, Allard JR, Peter CT. Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol. 1994;23(6):1342–55.CrossRef
9.
go back to reference Liang K, Zeger S. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13–22.CrossRef Liang K, Zeger S. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13–22.CrossRef
10.
go back to reference Quast ABE, Brouwer TF, Tjong FVY, Wilde AAM, Knops RE. Clinical parameters to optimize patient selection for subcutaneous and transvenous implantable defibrillator therapy. Pacing Clin Electrophysiol. 2018;41:990–5.CrossRef Quast ABE, Brouwer TF, Tjong FVY, Wilde AAM, Knops RE. Clinical parameters to optimize patient selection for subcutaneous and transvenous implantable defibrillator therapy. Pacing Clin Electrophysiol. 2018;41:990–5.CrossRef
11.
go back to reference Josephson ME. Recurrent ventricular tachycardia. In: Josephson ME, editor. Clinical cardiac electrophysiology. Techniques and interpretations, vol. 1. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 435–9. Josephson ME. Recurrent ventricular tachycardia. In: Josephson ME, editor. Clinical cardiac electrophysiology. Techniques and interpretations, vol. 1. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 435–9.
12.
go back to reference Callans DJ, Josephson ME. Ventricular tachycardia in patients with coronary artery disease. In: Zipes DP, editor. Cardiac electrophysiology. From cell to bedside. Philadelphia: Sauders; 2004. p. 569–74.CrossRef Callans DJ, Josephson ME. Ventricular tachycardia in patients with coronary artery disease. In: Zipes DP, editor. Cardiac electrophysiology. From cell to bedside. Philadelphia: Sauders; 2004. p. 569–74.CrossRef
13.
go back to reference Berte B, Sacher F, Venlet J, et al. VT recurrence after ablation: incomplete ablation or disease progression? A Multicentric European Study. J Cardiovasc Electrophysiol. 2016;27(1):80–7.CrossRef Berte B, Sacher F, Venlet J, et al. VT recurrence after ablation: incomplete ablation or disease progression? A Multicentric European Study. J Cardiovasc Electrophysiol. 2016;27(1):80–7.CrossRef
14.
go back to reference Mittal S, Lomnitz D, Mirchandani S, et al. Prognostic significance of nonsustained ventricular tachycardia after revascularization. J Cardiovasc Electrophysiol. 2002;13(4):342–6.CrossRef Mittal S, Lomnitz D, Mirchandani S, et al. Prognostic significance of nonsustained ventricular tachycardia after revascularization. J Cardiovasc Electrophysiol. 2002;13(4):342–6.CrossRef
16.
go back to reference Jimenez-Candil J, Hernandez J, Martin A, et al. Influence of cycle length variations on antitachycardia pacing effectiveness among ICD patients. Heart Rhythm. 2013;10(2):207–13.CrossRef Jimenez-Candil J, Hernandez J, Martin A, et al. Influence of cycle length variations on antitachycardia pacing effectiveness among ICD patients. Heart Rhythm. 2013;10(2):207–13.CrossRef
17.
go back to reference Anthony R, Daubert JP, Zareba W, et al. Mechanisms of ventricular fibrillation initiation in MADIT II patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2008;31(2):144–50.CrossRef Anthony R, Daubert JP, Zareba W, et al. Mechanisms of ventricular fibrillation initiation in MADIT II patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2008;31(2):144–50.CrossRef
18.
go back to reference Sweeney MO, Wathen MS, Volosin K, et al. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation. 2005;111(22):2898–905.CrossRef Sweeney MO, Wathen MS, Volosin K, et al. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation. 2005;111(22):2898–905.CrossRef
19.
go back to reference Cheng A, Joung B, Brown ML, et al. Characteristics of ventricular tachyarrhythmias and their susceptibility to antitachycardia pacing termination in patients with ischemic and nonischemic cardiomyopathy: a patient-level meta-analysis of three large clinical trials. J Cardiovasc Electrophysiol. 2020;31(10):2720–6.CrossRef Cheng A, Joung B, Brown ML, et al. Characteristics of ventricular tachyarrhythmias and their susceptibility to antitachycardia pacing termination in patients with ischemic and nonischemic cardiomyopathy: a patient-level meta-analysis of three large clinical trials. J Cardiovasc Electrophysiol. 2020;31(10):2720–6.CrossRef
20.
go back to reference Raitt MH, Klein RC, Wyse DG, et al. Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. Am J Cardiol. 2003;91(7):812–6.CrossRef Raitt MH, Klein RC, Wyse DG, et al. Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. Am J Cardiol. 2003;91(7):812–6.CrossRef
Metadata
Title
Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies
Authors
Javier Jiménez-Candil
Olga Duran
Armando Oterino
Jendri Pérez
Juan Carlos Castro
Jesús Hernández
José Moríñigo
Manuel Sánchez García
Pedro L. Sánchez
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2021
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-021-02087-2

Other articles of this Issue 1/2021

BMC Cardiovascular Disorders 1/2021 Go to the issue